Management of Migraine Using Enerumab and Traditional Therapy at the Time of COVID-19
Condition: Migraine Disorders Intervention: Drug: Erenumab Sponsor: Fayoum University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials